These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1123988

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients].
    Markova LI, Kuznetsova IV, Radzevich AE.
    Ter Arkh; 2004; 76(11):41-3. PubMed ID: 15658536
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Discriminatory function of hemorheological variables in peripheral arterial disease.
    Ernst E, Matrai A.
    Vasa; 1988; 17(2):98-101. PubMed ID: 3407320
    [No Abstract] [Full Text] [Related]

  • 25. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
    Caimi G, Catania A, Frazzetta F, Capobianco D, Francavilla G, Romano A, Sarno A.
    Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Studies on haematocrit in peripheral arterial disease.
    Lowe GD, Saniabadi A, Turner A, Lieberman P, Pollock J, Drury J.
    Klin Wochenschr; 1986 Oct 01; 64(19):969-74. PubMed ID: 3784449
    [Abstract] [Full Text] [Related]

  • 29. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E, Thiele P.
    Z Gesamte Inn Med; 1987 Mar 01; 42(5):137-41. PubMed ID: 3590891
    [Abstract] [Full Text] [Related]

  • 30. [Hemorrheological changes in peripheral obliterative arterial diseases].
    Bartoli V, Albanese B, Morini R, Pasquini G, Manescalchi PG.
    Ric Clin Lab; 1983 Mar 01; 13 Suppl 3():209-18. PubMed ID: 6672997
    [Abstract] [Full Text] [Related]

  • 31. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Mar 01; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blood viscosity, mass transport, and thrombogenesis.
    Turitto VT.
    Prog Hemost Thromb; 1982 Mar 01; 6():139-77. PubMed ID: 6762611
    [No Abstract] [Full Text] [Related]

  • 36. Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study.
    Koscielny J, Jung EM, Mrowietz C, Kiesewetter H, Latza R.
    Clin Hemorheol Microcirc; 2004 Mar 01; 31(3):185-95. PubMed ID: 15322324
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
    Di Perri T, Forconi S, Guerrini M, Rossi C, Pecchi S.
    Boll Soc Ital Cardiol; 1977 Mar 01; 22(7):1138-50. PubMed ID: 618247
    [No Abstract] [Full Text] [Related]

  • 40. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H, Dudczak R, Lechner K.
    Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.